Skip to main content
Akil Merchant, MD, Oncology, Los Angeles, CA

AkilAbidMerchantMD

Oncology Los Angeles, CA

Hematologic Oncology

Associate Professor of Medicine

Dr. Merchant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Merchant's full profile

Already have an account?

  • Office

    8700 Beverly Blvd., A9102
    Los Angeles, CA 90048
    Phone+1 310-423-1160

Summary

  • Dr. Akil Merchant is co-Director of the Lymphoma Program at Cedars-Sinai Medical Center in Los Angeles, CA. He did his fellowship in Medical Oncology at Johns Hopkins University and was on the faculty at LAC-USC and the USC Norris Cancer center. He specializes lymphoma treatment and cellular therapies including CART and bone marrow transplantation.

Clinical Expertise

  • Bone marrow transplantation, Leukemia, Hematologic oncology, Myeloproliferative disease, Oropharyngeal lymphoma

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2000 - 2005
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2025
  • MD State Medical License
    MD State Medical License 2005 - 2013
  • TX State Medical License
    TX State Medical License 2002 - 2005
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Highly Multiplexed Single Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Predicts Clinical Outcomes
    Akil Merchant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
    Akil Merchant, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Researchers Identify Patterns That Predict Ovarian Cancer Relapse
    Researchers Identify Patterns That Predict Ovarian Cancer RelapseApril 18th, 2024
  • A Leading-Edge Lymphoma Program
    A Leading-Edge Lymphoma ProgramDecember 21st, 2022
  • The More Pandemic Precautions Fall Away, the More COVID Risk Is Concentrated on This One Group
    The More Pandemic Precautions Fall Away, the More COVID Risk Is Concentrated on This One GroupDecember 2nd, 2022
  • Join now to see all